Globus Medical Return on Tangible Equity 2010-2024 | GMED

Current and historical return on tangible equity values for Globus Medical (GMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Globus Medical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $0.09B $1.80B 5.51%
2024-06-30 $0.04B $1.66B 2.45%
2024-03-31 $0.07B $1.58B 3.97%
2023-12-31 $0.12B $1.64B 7.20%
2023-09-30 $0.16B $1.80B 9.33%
2023-06-30 $0.20B $1.73B 12.55%
2023-03-31 $0.20B $1.66B 12.91%
2022-12-31 $0.19B $1.59B 12.43%
2022-09-30 $0.16B $1.53B 10.30%
2022-06-30 $0.16B $1.46B 10.38%
2022-03-31 $0.14B $1.54B 9.59%
2021-12-31 $0.15B $1.49B 10.45%
2021-09-30 $0.19B $1.48B 13.66%
2021-06-30 $0.18B $1.41B 14.15%
2021-03-31 $0.12B $1.33B 9.84%
2020-12-31 $0.10B $1.26B 8.61%
2020-09-30 $0.10B $1.21B 8.14%
2020-06-30 $0.09B $1.12B 7.75%
2020-03-31 $0.15B $1.15B 13.04%
2019-12-31 $0.16B $1.20B 14.01%
2019-09-30 $0.15B $1.13B 13.89%
2019-06-30 $0.14B $1.07B 14.29%
2019-03-31 $0.15B $1.03B 15.67%
2018-12-31 $0.16B $0.97B 17.33%
2018-09-30 $0.14B $0.93B 16.87%
2018-06-30 $0.14B $0.90B 16.80%
2018-03-31 $0.12B $0.82B 15.77%
2017-12-31 $0.11B $0.77B 14.92%
2017-09-30 $0.11B $0.73B 15.46%
2017-06-30 $0.11B $0.70B 16.01%
2017-03-31 $0.11B $0.70B 15.84%
2016-12-31 $0.10B $0.66B 16.16%
2016-09-30 $0.12B $0.63B 18.87%
2016-06-30 $0.12B $0.66B 19.53%
2016-03-31 $0.12B $0.62B 20.37%
2015-12-31 $0.11B $0.59B 21.12%
2015-09-30 $0.10B $0.55B 20.12%
2015-06-30 $0.10B $0.52B 19.94%
2015-03-31 $0.10B $0.49B 19.69%
2014-12-31 $0.09B $0.50B 19.19%
2014-09-30 $0.09B $0.51B 18.45%
2014-06-30 $0.08B $0.48B 18.62%
2014-03-31 $0.07B $0.45B 16.24%
2013-12-31 $0.07B $0.42B 16.71%
2013-09-30 $0.07B $0.42B 17.37%
2013-06-30 $0.06B $0.40B 17.29%
2013-03-31 $0.08B $0.38B 21.89%
2012-12-31 $0.07B $0.36B 22.95%
2012-09-30 $0.07B $0.34B 22.46%
2012-06-30 $0.07B $0.31B 31.85%
2012-03-31 $0.06B $0.28B 45.17%
2011-12-31 $0.06B $0.27B 84.53%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $11.345B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.480B 24.70
Intuitive Surgical (ISRG) United States $196.045B 102.50
Alcon (ALC) Switzerland $42.794B 28.63
Edwards Lifesciences (EW) United States $42.188B 26.79
IQVIA Holdings (IQV) United States $36.777B 20.26
IDEXX Laboratories (IDXX) United States $35.676B 42.01
DexCom (DXCM) United States $30.357B 45.72
Waters (WAT) United States $22.803B 33.72
STERIS (STE) Ireland $21.310B 24.53
SONOVA HOLDING (SONVY) Switzerland $20.157B 0.00
Hologic (HOLX) United States $17.098B 18.47
Fresenius Medical Care AG KGaA (FMS) Germany $14.119B 14.49
Sysmex ADR (SSMXY) Japan $13.255B 0.00
Penumbra (PEN) United States $9.105B 89.18
Masimo (MASI) United States $9.091B 43.99
Teleflex (TFX) United States $8.576B 13.68
Glaukos (GKOS) United States $7.735B 0.00
PROCEPT BioRobotics (PRCT) United States $4.949B 0.00
Integer Holdings (ITGR) United States $4.675B 26.50
Veracyte (VCYT) United States $3.420B 102.63
Inari Medical (NARI) United States $2.990B 0.00
LivaNova (LIVN) United Kingdom $2.699B 15.58
Nihon Kohden (NHNKY) Japan $2.361B 17.93
TransMedics (TMDX) United States $2.291B 72.62
Elekta AB (EKTAY) Sweden $2.165B 19.47
Tandem Diabetes Care (TNDM) United States $1.978B 0.00
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
RxSight (RXST) United States $1.739B 0.00
Alphatec Holdings (ATEC) United States $1.365B 0.00
Artivion (AORT) United States $1.243B 82.39
Pulse Biosciences (PLSE) United States $1.215B 0.00
OPKO Health (OPK) United States $1.085B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.849B 14.43
Paragon 28 (FNA) United States $0.840B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.687B 37.11
Mesa Laboratories (MLAB) United States $0.674B 15.88
AxoGen (AXGN) United States $0.656B 0.00
SiBone (SIBN) United States $0.567B 0.00
OrthoPediatrics (KIDS) United States $0.561B 0.00
Pacific Biosciences Of California (PACB) United States $0.556B 0.00
Semler Scientific (SMLR) United States $0.512B 30.12
Treace Medical Concepts (TMCI) United States $0.494B 0.00
Tactile Systems Technology (TCMD) United States $0.439B 23.75
Delcath Systems (DCTH) United States $0.380B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
CVRx (CVRX) United States $0.327B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
Inogen (INGN) United States $0.226B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Accuray (ARAY) United States $0.202B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.174B 0.00
Nevro (NVRO) United States $0.157B 0.00
Atossa Genetics (ATOS) United States $0.153B 0.00
Sensus Healthcare (SRTS) United States $0.145B 15.49
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
Vicarious Surgical (RBOT) United States $0.095B 0.00
WORK Medical Technology Group (WOK) China $0.092B 0.00
LENSAR (LNSR) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
908 Devices (MASS) United States $0.080B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.054B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.040B 0.00
Spectral AI (MDAI) United States $0.039B 0.00
Neuronetics (STIM) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00